Does addition of erythropoiesis stimulating agents improve the outcome of higher-risk myelodysplastic syndromes treated with azacitidine?

Saved in:
Bibliographic Details
Title: Does addition of erythropoiesis stimulating agents improve the outcome of higher-risk myelodysplastic syndromes treated with azacitidine?
Authors: Itzykson, R.1, Thépot, S.1, Beyne-Rauzy, O.2, Ame, S.3, Isnard, F.4, Dreyfus, F.5, Salanoubat, C.6, Taksin, A.L.7, Chelgoum, Y.8, Berthon, C.9, Malfuson, J.V.10, Legros, L.11, Vey, N.12, Turlure, P.13, Gardin, C.1, Boehrer, S.1, Ades, L.1, Fenaux, P.1 Pierre.fenaux@avc.aphp.fr
Source: Leukemia Research. Apr2012, Vol. 36 Issue 4, p397-400. 4p.
Database: Academic Search Ultimate
Description
ISSN:01452126
DOI:10.1016/j.leukres.2011.11.019